tm
Seeing Is Believing
tm
Seeing Is Believing
CNTA is currently covered by 5 analysts with an average price target of $28.37. This is a potential upside of $7.04 (33.01%) from yesterday's end of day stock price of $21.33.
Centessa Pharmaceuticals PLC ADR's activity chart (see below) currently has 33 price targets and 36 ratings on display. The stock rating distribution of CNTA is 11.76% SELL, 76.47% BUY and 11.76% HOLD.
Analysts average stock forecasts to be materialized ratio is 71.2% with an average time for these price targets to be met of 188.44 days.
Highest price target for CNTA is $40, Lowest price target is $28, average price target is $30.5.
Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 29-Aug-2025. First documented stock forecast 22-Jun-2021.
Currently out of the existing stock ratings of CNTA, 2 are a SELL (11.76%), 13 are a BUY (76.47%), 2 are a HOLD (11.76%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$40
$18.19 (83.40%)
$14
18 days ago
(29-Aug-2025)
2/3 (66.67%)
$23.21 (138.24%)
35
Buy
$28
$6.19 (28.38%)
5 months 21 days ago
(26-Mar-2025)
2/5 (40%)
$13.46 (92.57%)
213
$11
11 months 27 days ago
(20-Sep-2024)
7/8 (87.5%)
$1.9 (20.88%)
411
Buy
$35
$13.19 (60.48%)
$20
1 years ago
(16-Sep-2024)
4/5 (80%)
$18.54 (112.64%)
375
Buy
$19
$-2.81 (-12.88%)
$11
1 years 5 days ago
(11-Sep-2024)
2/2 (100%)
$5.25 (38.18%)
121
What is CNTA (Centessa Pharmaceuticals PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on CNTA (Centessa Pharmaceuticals PLC ADR) with a proven track record?
Which analyst has the current lower performing score on CNTA (Centessa Pharmaceuticals PLC ADR) with a proven track record?
Which analyst has the most public recommendations on CNTA (Centessa Pharmaceuticals PLC ADR)?
Which analyst is the currently most bullish on CNTA (Centessa Pharmaceuticals PLC ADR)?
Which analyst is the currently most reserved on CNTA (Centessa Pharmaceuticals PLC ADR)?
